15 December 2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
CEO/ C-suite/ Board
| Function | Focus area | Location |
|---|---|---|
| Chief Technology Officer | Biomanufacturer (mid-cap) | US |
| Chief Medical Officer | Biotech (mid-cap) | Europe |
| Chief Financial Officer | Surgical precision solutions (publicly listed) | Europe |
| Chief Commercial Officer | Biotech (publicly listed) | Canada/ US |
| Board Director | Biopharma (publicly listed) | US |
| Board Director | Biotech (publicly listed) | Canada |
| Board Director | Medical devices (publicly listed) | US |
Commercial / Functional / Strategic Leadership
| Function | Focus area | Location |
|---|---|---|
| Head Business Development & Strategy | Phytopharmaceutical products (mid-cap) | Europe |
| Head of Commercial Biologics | Contract development and manufacturing organization (publicly listed) | US |
| Head of Global Marketing | Pharma (family-owned mid-cap) | Europe |
| VP Marketing | Biotech (mid-cap) | US |
| VP Government Affairs & Health Economics | Surgical products (mid-cap) | Europe |
| VP Finance | Biopharma (mid-cap) | Europe |
| General Manager, Pulmonary | Advanced diagnostics (publicly listed) | US |
| General Manager Poland | Medical devices & instruments (large-cap) | Europe |
| Associate Director to the Senior Management Team | Pharma (top 10 global) | Europe |
| Marketing Director EMEA | Medtech (large-cap) | Europe/ APAC |
| Industrial Operations Corporate Director | Animal health pharma (top 5 global) | Europe |
R&D/ Medical/ Technical
| Function | Focus area | Location |
|---|---|---|
| Global Head of Drug Design | Biopharma (large-cap) | Europe |
| Group Head of Regulatory Affairs | Pharma (mid-cap) | Europe |
| Global Head of R&D | Women's health (mid-cap) | US |
| Chief Research & Innovation Officer | FMCG (large-cap) | Europe |
| Head of Chemistry | Specialty pharma (mid-cap) | Europe |
| Head of Clinical Development | Pharma (mid-cap) | Europe |
| Head of Medical Affairs Europe and Japan | Drug delivery (mid-cap) | Europe |
| EVP Technical Operations | Biopharma (publicly listed) | US |
| Director Global QA Excellence | Surgical products (large-cap) | Europe |
| Health Economist x 2 | Medtech and industrial services (large-cap) | Europe |
Related
-
Thought Leadership
Necessarily Different: a continuous global study of the work styles and leadership impact of digital health CEOs and Founders
26 February 2024
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Press Releases
Coulter Partners places Vice President of Intellectual Property at Amphista Therapeutics
09 March 2023
-
Press Releases
Coulter Partners places two industry-leading infectious disease experts as Board Directors at RQ Bio
14 February 2023